Abstract
The simultaneous occurrence of behavioral, neurophysiological, and autonomic descriptors conventionally defines each physiologic state of being. When functional or anatomical abnormalities involve the structures of the network orchestrating the synchronization of these descriptors, features of a state of being are erroneously recruited into an ongoing state, generating aberrant conditions. Several deviant patterns may occur, such as hypnagogic or hypnopompic hallucinations, automatic behaviors, sleep drunkenness, cataplexy, and sleep paralysis due to intrusion of other states of being while awake; REM sleep behavior disorder and lucid dreaming due to the intrusion of features of wakefulness while in REM sleep; and the disorders of arousal, for the intrusion of features of wakefulness while in NREM sleep (according to the conventional way or interpretation adopted in the chapter).
Status dissociatus labels the extreme expression of the breakdown in the boundaries of state determinants. It ranges from conditions characterized by state instability with subcontinuous state transitions, as seen in autoimmune encephalitis and type 1 narcolepsy, to extreme conditions where state of being can no longer be identified.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ADCA-DN:
-
Dominant cerebellar ataxia, deafness, and narcolepsy
- caspr2:
-
Contactin-associated protein 2
- CSF:
-
Cerebrospinal fluid
- EEG:
-
Electroencephalography
- EMG:
-
Electromyography
- GBS:
-
Guillain-Barré syndrome
- Hcrt:
-
Hypocretin
- Lgi1:
-
Leucine-rich glioma-inactivated 1
- MSA:
-
Multiple system atrophy
- NT1:
-
Type 1 narcolepsy
- NMDA:
-
Anti-N-methyl-d-aspartate
- PD:
-
Parkinson’s disease
- PLMs:
-
Periodic leg movements
- PSG:
-
Polysomnography
- RBD:
-
REM sleep behavior disorder
- REM:
-
Rapid eyes movement
- RSWA:
-
REM sleep without atonia
- SD:
-
Status dissociatus
- SOREMP:
-
REM sleep onset periods
- VGKC-Ab:
-
Voltage-gated potassium channel complex antibodies
- W:
-
Wake
References
Raynal D. Polygraphic aspects of narcolepsy. In: Guilleminault C, Dement WC, Passouant P, editors. Narcolepsy. Advance in sleep research, vol. 3. New York: Spectrum Publications; 1976. p. 671–84.
Mahowald MW, Schenck CH. Status dissociatus—a perspective on states of being. Sleep. 1991;14:69–79.
Antelmi E, Ferri R, Iranzo A, Arnulf I, Dauvilliers Y, Bhatia KP, Liguori R, Schenck CH, Plazzi G. From state dissociation to status dissociatus. Sleep Med Rev. 2016;28:5–17.
Wamsley E, Donjacour CE, Scammell TE, Lammers GJ, Stickgold R. Delusional confusion of dreaming and reality in narcolepsy. Sleep. 2014;37:419–22.
Arnulf I, Bonnet AM, Damier P, Bejjani BP, Seilhean D, Derenne JP, et al. Hallucinations, REM sleep, and Parkinson’s disease: a medical hypothesis. Neurology. 2000;55:281–8.
Szklo-Coxe M, Young T, Finn L, Mignot E. Depression: relationships to sleep paralysis and other sleep disturbances in a community sample. J Sleep Res. 2007;16:297–312.
Mahowald MW, Schenck CH. NREM parasomnias. Neurol Clin. 1996;14:675–96.
Ohayon MM, Mahowald MW, Dauvilliers Y, Krystal AD, Léger D. Prevalence and comorbidity of nocturnal wandering in the U.S. adult general population. Neurology. 2012;78:1583–9.
Heidbreder A, Frauscher B, Mitterling T, Boentert M, Schirmacher A, Hörtnagl P, et al. Not only sleepwalking but NREM parasomnia irrespective of the type is associated with HLA DQB1*05:01. J Clin Sleep Med. 2016;12:565–70.
Terzaghi M, Ratti PL, Manni F, Manni R. Sleep paralysis in narcolepsy: more than just a motor dissociative phenomenon? Neurol Sci. 2012;33:169–72.
Bassetti C, Vella S, Donati F, Wielepp P, Weder B. SPECT during sleepwalking. Lancet. 2000;356:484–5.
Heidbreder A, Stefani A, Brandauer E, Steiger R, Kremser C, Gizewski ER, et al. Gray matter abnormalities of the dorsal posterior cingulate in sleep walking. Sleep Med. 2017;36:152–5.
Cochen V, Arnulf I, Demeret S, Neulat ML, Gourlet V, Drouot X, et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain. 2005;128:2535–45.
Compta Y, Iranzo A, Santamarıa J, Iranzo A, Santamaría J, Casamitjana R, Graus F. REM sleep behavior disorder and narcoleptic features in anti-Ma2-associated encephalitis. Sleep. 2007;30:767–9.
Cornelius JR, Pittock SJ, McKeon A, Lennon VA, Aston PA, Josephs KA, et al. Sleep manifestations of voltage-gated potassium channel complex autoimmunity. Arch Neurol. 2011;68:733–8.
Dauvilliers Y, Bauer J, Rigau V, Lalloyer N, Labauge P, Carlander B, et al. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy. JAMA Neurol. 2013;70:1305–10.
Iranzo A, Graus F, Clover L, Morera J, Bruna J, Vilar C, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59:178–81.
Overeem S, Dalmau J, Bataller L, Nishino S, Mignot E, Verschuuren J, et al. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis. Neurology. 2004;62:138–40.
Dodet P, Chavez M, Leu-Semenescu S, Golmard J, Arnulf I. Lucid dreaming in narcolepsy. Sleep. 2015;38:487–97.
La Berge SP, Nagel LE, Dement WC, Zarcone VP Jr. Lucid dreaming verified by volitional communication during REM sleep. Percept Mot Skills. 1981;52:727–32.
Liguori R, Vincent A, Clover L, Avoni P, Plazzi G, Cortelli P, et al. Morvan’s syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124:2417–26.
Lugaresi E, Provini F. Agrypnia excitata: clinical features and pathophysiological implications. Sleep Med Rev. 2001;5:313–22.
Montagna P, Lugaresi E. Agrypnia excitata: a generalized overactivity syndrome and a useful concept in the neurophysiology of sleep. Clin Neurophysiol. 2002;113:552–60.
Mahowald MW, Schenck CH. Dissociated states of wakefulness and sleep. Neurology. 1992;42:44–51.
Lugaresi E, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, et al. Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. N Engl J Med. 1986;315:997–1003.
Bakiston’s Gould medical dictionary. 3rd ed. New York: McGraw-Hill; 1931.
Medori R, Tritschler HJ, LeBlanc A, Villare F, Manetto V, Chen HY, et al. Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med. 1992;326:444–9.
Abgrall G, Demeret S, Rohaut B, Leu-Semenescu S, Arnulf I. Status dissociatus and disturbed dreaming in a patient with Morvan syndrome plus myasthenia gravis. Sleep Med. 2015;16:894–6.
Löscher WN, Wanschitz J, Reiners K, Quasthoff S. Morvan’s syndrome: clinical, laboratory, and in vitro electrophysiological studies. Muscle Nerve. 2004;30:157–63.
Plazzi G, Montagna P, Meletti S, Lugaresi E. Polysomnographic study of sleeplessness and oneiricisms in the alcohol withdrawal syndrome. Sleep Med. 2002;3:279–82.
Plazzi G, Schutz Y, Cortelli P, Provini F, Avoni P, Heikkila E, et al. Motor overactivity and loss of motor circadian rhythm in fatal familial insomnia: an actigraphic study. Sleep. 1997;20:739–42.
Ferri R, Lanuzza B, Consentino FL, Iero I, Russo N, Tripodi M, et al. Agrypnia excitata in a patient with progeroid short stature and pigmented nevi (Mulvihill-Smith syndrome). J Sleep Res. 2005;14:463–70.
Yagihashi T, Kato M, Izumi K, Kosaki R, Yago K, Tsubota K, et al. Case report: adult phenotype of Mulvihill-Smith syndrome. Am J Med Genet A. 2009;149A:496–500.
Rodriguez-Porcel F, Lowder L, Rademakers R, Ravenscroft T, Ghetti B, Hagen MC, Espay AJ. Fulminant corticobasal degeneration: Agrypnia excitata in corticobasal syndrome. Neurology. 2016;86:1164–6.
Vetrugno R, Alessandria M, D’Angelo R, Plazzi G, Provini F, Cortelli P, et al. Status dissociatus evolving from REM sleep behaviour disorder in multiple system atrophy. Sleep Med. 2009;10:247–52.
Broughton R, Valley V, Aguirre M, Roberts J, Suwalski W, Dunham W. Excessive daytime sleepiness and the pathophysiology of narcolepsy-cataplexy: a laboratory perspective. Sleep. 1986;9:205–15.
Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, et al. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain. 2011;134:3480–92.
Antelmi E, Pizza F, Vandi S, Neccia G, Ferri R, Bruni O, et al. The spectrum of rapid-eye-movement sleep related episodes in children with type 1 Narcolepsy. Brain. 2017;140:1669–79.
van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MA, et al. Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology. 2016;87:1449–56.
Peter-Derex L, Devic P, Rogemond V, Rheims S, Mauguière F, Honnorat J. Full recovery of agrypnia associated with anti-Lgi1 antibodies encephalitis under immunomodulatory treatment: a case report with sequential polysomnographic assessment. Sleep Med. 2012;13:554–6.
Tezer FI, Erdener E, Sel CG, Mehdikanova L, Saygi S, Topcuoglu M. Daytime polysomnography recording in LIG1-related limbic encephalitis. Arch Neurol. 2012;65:145–6.
Dalmau J, Graus F, Villarejo A, et al. Clinical analysis of anti-Ma2-associated encephalitis. Brain. 2004;127:1831–44.
Adams C, McKeon A, Silber MH, Kumar R. Narcolepsy REM sleep behavior disorder, and supranuclear gaze palsy associated with Ma1 and Ma2 antibodies and tonsillar carcinoma. Arch Neurol. 2011;68:521–4.
Haitao R, Yingmai Y, Yan H, Fei H, Xia L, Honglin H, Chaiyan L, et al. Chorea and parkinsonism associated with autoantibodies to IgLON5 and responsive to immunotherapy. J Neuroimmunol. 2016;300:9–10.
Högl B, Heidbreder A, Santamaria J, Graus F, Poewe W. IgLON5 autoimmunity and abnormal behaviours during sleep. Lancet. 2015;385:1590.
Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, et al. A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol. 2014;13:575–86.
Simabukuro MM, Sabater L, Adoni T, Cury RG, Haddad MS, Moreira CH, et al. Sleep disorder, chorea, and dementia associated with IgLON5 antibodies. Neurol Neuroimmunol Neuroinflamm. 2015;2:e136.
Gelpi E, Höftberger R, Graus F, Ling H, Holton JL, Dawson T, et al. Neuropathological criteria of anti-IgLON5-related tauopathy. Acta Neuropathol. 2016;132:531–43.
Scammell TE, Arrigoni E, Lipton JO. Neural circuitry of wakefulness and sleep. Neuron. 2017;93:747–65.
de Lecea L, Huerta R. Hypocretin (orexin) regulation of sleep-to-wake transitions. Front Pharmacol. 2014;5:16.
Hu B, Yang N, Qiao QC, Hu ZA, Zhang J. Roles of the orexin system in central motor control. Neurosci Biobehav Rev. 2015;49:43–54.
Magnin M, Rey M, Bastuji H, Guillemant P, Mauguiere F, Garcia-Larrea L. Thalamic deactivation at sleep onset precedes that of the cerebral cortex in humans. Proc Natl Acad Sci U S A. 2010;107:3829–33.
Note Added in Proof
An additional case has recently been published: 1) Puligheddu M, Congiu P, Laccu I, et al. Overlap parasomnia disorder in a case of Creutzfeldt-Jakob disease. Sleep Med. 2017;36:75–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Antelmi, E., Plazzi, G. (2019). Status Dissociatus and Its Relation to RBD. In: Schenck, C., Högl, B., Videnovic, A. (eds) Rapid-Eye-Movement Sleep Behavior Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-90152-7_28
Download citation
DOI: https://doi.org/10.1007/978-3-319-90152-7_28
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-90151-0
Online ISBN: 978-3-319-90152-7
eBook Packages: MedicineMedicine (R0)